Search All News
A recent rise in a rare lymphoma has been linked to breast implants, but Columbia researchers have found that the risk is extremely low among women who have reconstructive surgery after mastectomy.
Bad weather forced the cancellation of the in-person cycling fundraiser, but participants organized their own bike rides and raised $1.1 million for cancer research and patient care at Columbia.
Jan Hilgeman is one of the rare long-term survivors of pancreatic cancer, and Columbia researchers are now studying her cells in hopes of developing a potential treatment for others with the disease.
An implantable pump that has the potential to transform brain cancer treatment was found safe and effective in people in a study at Columbia University.
- November 1, 2022
Columbia's Barbara Pro, MD, widely recognized for her expertise in developing novel drug treatments for lymphoma, shares her insights.
- October 21, 2022
High school students from the Herbert Irving Comprehensive Cancer Center's summer science program presented their research findings to Columbia scientists at an Oct. 17 poster session.
- October 20, 2022
A new study shows that a shift from quiescent to activated liver cells sets the stage for liver cancer and suggests ways to reduce the risk of developing the cancer in people with liver disease.
- September 29, 2022
Columbia’s Center for Comprehensive Wellness offers integrative treatments like acupuncture and massage to support cancer patients during their treatment with chemotherapy and radiation.
- September 28, 2022
After skin cancer, prostate cancer is the most common cancer diagnosed among men in the United States, and about one in eight men will be diagnosed with the disease during their lifetime.
- September 21, 2022
As part of the Biden Administration's Cancer Moonshot initiative, First Lady Jill Biden and Queen Letizia of Spain visited Columbia University's cancer center on Sept. 21.
- September 21, 2022
Jill Biden and Queen Letizia learned about the cancer center's work to transform care, improve diversity and access in clinical trials, and promote diversity and inclusion in science and medicine.
- September 7, 2022
The symposium will feature keynotes by Margaret Foti, chief executive at AACR, and Ned Sharpless, former director of the NCI, along with talks from leading members of the cancer center.